Health Care Ethics Institute Founded At City of Hope

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 4 No 8
Volume 4
Issue 8

LOS ANGELES--In response to the questions being raised by new medical technologies and managed health care, City of Hope has established its Institute for Applied Health Care Ethics on its 100-acre Duarte, Calif, campus.

LOS ANGELES--In response to the questions being raised by newmedical technologies and managed health care, City of Hope hasestablished its Institute for Applied Health Care Ethics on its100-acre Duarte, Calif, campus.

Coretta Scott King, widow of civil rights leader Dr. Martin LutherKing, Jr., spoke at the Institute's dedication ceremony. Mrs.King is president and CEO of The King Center for Nonviolent SocialChange in Atlanta.

"The Institute for Applied Health Care Ethics brings togetherscientists, ethics scholars, policy and legislative specialists,students, and clinicians to encourage discussion and debate onissues in clinical and health care ethics," said City ofHope President and CEO Sanford Shapero.

The Institute's first event was The Genome Imperative conferencefocusing on the ethical considerations surrounding genetic testingand therapy.

Dr. Shapero said that the formation of the Institute was a naturalevolution for City of Hope. "By virtue of our recognizedleadership in cancer research and bone marrow transplantation,we believe that the City of Hope is uniquely qualified to carrygene therapy forward into the 21st century," he said.

"But along with that commitment to solid research and medicinecomes the responsibility to be held accountable for the humanvalue elements of our industry. We have chosen to assume the leadin that position as well."

Dr. Norman T. Mendel, Rabbi, has been named the Institute's firstdirector. He previously has served as the chairman of City ofHope's Pastoral Care Services and continues in that capacity.

Recent Videos
Educating community practices on CAR T referral and sequencing treatment strategies may help increase CAR T utilization.
The FirstLook liquid biopsy, when used as an adjunct to low-dose CT, may help to address the unmet need of low lung cancer screening utilization.
An 80% sensitivity for lung cancer was observed with the liquid biopsy, with high sensitivity observed for early-stage disease, as well.
9 Experts are featured in this series.
9 Experts are featured in this series.
Harmonizing protocols across the health care system may bolster the feasibility of giving bispecifics to those with lymphoma in a community setting.
2 experts are featured in this series.
Patients who face smoking stigma, perceive a lack of insurance, or have other low-dose CT related concerns may benefit from blood testing for lung cancer.
9 Experts are featured in this series.
Related Content